DISHMAN CARBOGEN AMCIS LIMITED Share Price & Technical Analysis
DCAL · ₹150.4 (-4.52%)
Healthcare / Biotechnology
₹150.4
-4.52%
Dishman Carbogen Amcis Limited provides contract development and manufacturing organization (CDMO) services for the pharmaceutical and healthcare industries worldwide. It operates through Integrated CDMO Platform and Marketable Molecules segments. The company offers cholesterol and vitamin D analogs; soft gel capsules and formulations; intermediate and active pharmaceutical ingredients (APIs) whic…
Price chart
Seasonality
Oct has 3 positive and 1 negative years (last 5 years shown)
-35% return in 2026, 38% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -12% | -18% | -23% | 34% | 5% | -10% | 6% | -5% | -12% | – | – | – | -35% |
| 25 | -14% | -13% | 9% | -10% | 37% | -6% | 1% | 3% | 5% | 6% | -18% | 3% | 2% |
| 24 | 14% | 23% | -8% | -2% | -33% | 6% | 14% | -1% | -11% | 8% | 27% | 10% | 46% |
| 23 | -11% | 38% | 5% | 10% | -15% | 19% | 12% | -3% | 4% | -12% | 14% | 4% | 66% |
| 22 | -3% | -16% | 13% | -11% | -28% | -5% | 10% | -9% | -17% | 3% | 0% | -5% | -68% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
Dishman Carbogen Amcis Limited provides contract development and manufacturing organization (CDMO) services for the pharmaceutical and healthcare industries worldwide. It operates through Integrated CDMO Platform and Marketable Molecules segments. The company offers cholesterol and vitamin D analogs; soft gel capsules and formulations; intermediate and active pharmaceutical ingredients (APIs) which cover specific therapeutic areas, such as anesthetics, and contrast media agents for diagnostics, ophthalmic treatments, laxatives, and organophosphate antidotes; ammonium and phosphonium; quats, phosphoranes, and wittig reagents; generic intermediates; cholesterol and lanolin-related products; sterile injectables; specialty chemicals and disinfectants, as well as hand and body wash, sanitizers, and antiseptic formulations. It also provides encapsulation and formulation capabilities; phase transfer catalysts; drug product, finished, and HiPo formulations; generic and highpotent APIs; Health and personal care solutions; and drug linkers and payloads. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹26.63B
P/E ratio
27.31
52W high
₹306.0
52W low
₹128.5
Volume
4,48,618
Beta
0.61
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,731
Frequently asked questions
- What is DISHMAN CARBOGEN AMCIS LIMITED share price today?
- DISHMAN CARBOGEN AMCIS LIMITED (DCAL) last traded around ₹150.4 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does DCAL have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for DCAL. Download the app for real-time alerts.
- How can I analyze DISHMAN CARBOGEN AMCIS LIMITED stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.